See more : Mori Hills REIT Investment Corporation (3234.T) Income Statement Analysis – Financial Results
Complete financial analysis of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF.MI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fine Foods & Pharmaceuticals N.T.M. S.p.A., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Teka Tecelagem Kuehnrich S.A. (TEKA3.SA) Income Statement Analysis – Financial Results
- Orbital Energy Group, Inc. (OEG) Income Statement Analysis – Financial Results
- Bluerock Residential Growth REIT, Inc. (BRG) Income Statement Analysis – Financial Results
- The Allstate Corporation (ALS.DE) Income Statement Analysis – Financial Results
- Fujimi Incorporated (5384.T) Income Statement Analysis – Financial Results
Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF.MI)
About Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders and granules, capsules, tablets, film-coated tablets, effervescent granules, and hard gelatine capsules. The company also provides nutraceutical products comprising soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatin capsules for various therapeutic areas, such as probiotics, multivitamins and minerals, immune systems, sleep and relax, gastrointestinal system, circulatory system, osteoarticular system, urinary system, women health, beauty, healthy ageing, and mental wellbeing. In addition, the company manufactures and trades in cosmetics products consisting of hair care, skin care, liquid detergents for personal hygiene, skin care emulsions, oral hygiene, deodorants, alcohol-based perfumery, bath and shower gel, shampoo and conditioners, shaping waxes, mouthwash and breath products, creams, gel and toothpaste, roll-on, stick and vapo spray deodrants, intimate cleansers, emulsions and microemulsions, gels, and liquid soaps; medical surgical aids and medical devices; antiseptics for undamaged skin, hand gel, pre-injection, hydroalcoholic surfaces, and iodine; and orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. The company was founded in 1984 and is headquartered in Verdellino, Italy.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 251.81M | 206.85M | 194.42M | 173.03M | 159.66M | 139.39M | 0.00 | 0.00 |
Cost of Revenue | 184.08M | 153.22M | 139.52M | 123.80M | 113.36M | 98.30M | 21.98K | 2.98K |
Gross Profit | 67.74M | 53.63M | 54.90M | 49.23M | 46.30M | 41.09M | -21.98K | -2.98K |
Gross Profit Ratio | 26.90% | 25.93% | 28.24% | 28.45% | 29.00% | 29.48% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.52M | 24.38M | 17.18M | 1.52M | 1.41M | 0.00 | 189.95K | 48.07K |
Selling & Marketing | 605.76K | 312.41K | 564.41K | 233.76K | 575.58K | 0.00 | 0.00 | 0.00 |
SG&A | 2.13M | 24.70M | 17.74M | 1.52M | 11.90M | 10.71M | 189.95K | 48.07K |
Other Expenses | 64.54M | 53.34M | 47.97M | 40.78M | 40.52M | 32.61M | 454.98K | 225.04K |
Operating Expenses | 66.67M | 53.34M | 47.97M | 42.30M | 40.52M | 32.61M | 644.93K | 273.10K |
Cost & Expenses | 250.75M | 206.57M | 187.50M | 166.11M | 153.88M | 130.91M | 666.91K | 276.08K |
Interest Income | 276.96K | 5.51K | 1.59K | 320.00 | 521.00 | 751.98K | 479.49K | 83.82K |
Interest Expense | 4.81M | 2.08M | 700.96K | 484.68K | 774.53K | 518.78K | 0.00 | 2.29K |
Depreciation & Amortization | 16.13M | 15.45M | 13.40M | 11.64M | 9.36M | 7.74M | 419.41K | 216.88K |
EBITDA | 19.29M | 3.64M | 9.86M | 29.18M | 10.30M | 18.66M | 258.32K | 34.35K |
EBITDA Ratio | 7.66% | 6.63% | 10.76% | 12.96% | 11.73% | 13.48% | 0.00% | 0.00% |
Operating Income | 1.07M | -1.75M | 7.52M | 10.79M | 8.60M | 11.06M | -187.41K | -192.26K |
Operating Income Ratio | 0.42% | -0.85% | 3.87% | 6.24% | 5.39% | 7.93% | 0.00% | 0.00% |
Total Other Income/Expenses | -2.92M | -12.45M | -11.94M | 10.83M | -7.30M | -628.88K | 0.00 | 71.30K |
Income Before Tax | -1.86M | -14.20M | -4.59M | 16.68M | 7.72M | 10.43M | -187.41K | -194.55K |
Income Before Tax Ratio | -0.74% | -6.86% | -2.36% | 9.64% | 4.84% | 7.48% | 0.00% | 0.00% |
Income Tax Expense | 1.67M | -4.70M | -3.16M | 3.32M | 1.66M | 1.74M | 452.60K | 2.29K |
Net Income | -3.52M | -9.50M | -1.43M | 13.36M | 6.07M | 8.69M | -187.41K | -196.84K |
Net Income Ratio | -1.40% | -4.59% | -0.73% | 7.72% | 3.80% | 6.23% | 0.00% | 0.00% |
EPS | -0.14 | -0.39 | -0.06 | 0.58 | -0.12 | 0.85 | -0.02 | -0.02 |
EPS Diluted | -0.14 | -0.39 | -0.06 | 0.55 | -0.12 | 0.85 | -0.02 | -0.02 |
Weighted Avg Shares Out | 25.16M | 24.54M | 23.94M | 23.18M | 22.69M | 10.20M | 10.20M | 10.20M |
Weighted Avg Shares Out (Dil) | 25.16M | 24.54M | 23.94M | 24.46M | 22.69M | 10.20M | 10.20M | 10.20M |
Source: https://incomestatements.info
Category: Stock Reports